- 04 May 2017
- Duration: 1:34
Women who inherit a faulty BRCA1 gene have a really high risk of developing breast cancer, yet despite this high risk they have very few options for breast cancer prevention.
I was really driven to find an alternative strategy for breast cancer prevention of BRCA1 mutation carriers as these women are currently limited to evasive breast removal surgery to minimise their risk.
I feel very honoured to be the recipient of the 2017 Premier's Award for Health and Medical Research, for me this award is really validation for the value of my research and the contribution that I have made to the breast cancer community.
To encourage women into health and medical research, I think we really need to increase the numbers of women in higher leadership positions such as lab heads and professors and this will provide more role models for younger women in schools and in universities.
So I think one of the ways we can do this is to really encourage women with children to return to the workforce. The Walter and Eliza Institute is making great progress in this area, for example through the establishment of an on-site early childcare centre. This should really help women return to work and help them balance family and work life and hopefully with the success of this initiative this will encourage other research institutes and universities to follow suit.
I really aspire to be a bold scientist. I'd like to be known as a scientist who isn't afraid to ask big questions and step outside the box in order to make major contributions to medical research.
Emma Nolan talks about the research into the BRCA1 gene that led to her being awarded the 2017 Premier's Award for Health and Medical Research.
Reviewed 04 May 2017